You have no items in your shopping cart.
Mouse VEGF-D [orb2994004]Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 13.1 KDa. Observed: 17-20 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg- Human VEGFB [orb2994163]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 45.7 KDa. Observed: 40&60 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Rat VEGF 164 [orb2994452]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 19.2 KDa. Observed: 18-23 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Human VEGF-D [orb2995034]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 13 KDa. Observed: 18 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Human VEGF 121 [orb2994925]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 14.2 KDa. Observed: 16 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Human VEGF 121 [orb2994931]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.. SEC-HPLC: Greater than 90% as determined by SEC-HPLC.(QC verified)
Predicted: 15.1 KDa. Observed: 16-18 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Human VEGF-C [orb2995003]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.. SEC-HPLC: Greater than 85% as determined by SEC-HPLC.(QC verified)
Predicted: 23.27 KDa. Observed: 25-30 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Item 1 of 1Featured
Active
> 96 % by SDS-PAGE and HPLC analyses.
Approximately 11.5 kDa, a single non-glycosylated polypeptide chain containing 98 amino acids.
Escherichia coli
5 μg, 100 μg, 500 μg - Item 1 of 1
- Item 1 of 1Human VEGF 165 protein [orb178366]
SDS-PAGE
Unconjugated
> 85% as determined by SDS-PAGE
0.5 mg, 1 mg, 0.1 mg
